Statera BioPharma Inc (STAB)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Michael Kevin Handley
Employees:
16
2537 RESEARCH BOULEVARD, SUITE 201, FORT COLLINS, CO, 80526
(888) 613-8802

Statera BioPharma, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops novel second generation immune therapies to deliver immune homeostasis based on proprietary platforms. Statera BioPharma serves customers worldwide.

Data derived from most recent annual or quarterly report
Market Cap 90.288 Million Shares Outstanding25.65 Million Avg 30-day Volume 184.436 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.47
Price to Revenue1939.9663 Debt to Equity0.0 EBITDA-2.665 Million
Price to Book Value9.8804 Operating Margin-6347.8679999999995 Enterprise Value75.851 Million
Current Ratio45.984 EPS Growth-0.056 Quick Ratio45.828
1 Yr BETA 1.5453 52-week High/Low 10.97 / 2.11 Profit Margin-6126.4727
Operating Cash Flow Growth-36.1218 Altman Z-Score152.2862 Free Cash Flow to Firm -2.165 Million
View SEC Filings from STAB instead.

View recent insider trading info

Funds Holding STAB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding STAB BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MARKVICKA TAUNIA CHIEF OPERATING OFFICER

  • Officer
  • Director
100,000 2021-09-28 2

BARBARICK STEVE K

  • Director
60,000 2021-09-09 2

SALUCK RANDY S.

  • Director
60,140 2021-09-09 1

VERNY LEA

  • Director
60,000 2021-09-09 1

ARONSTAM PETER CHIEF FINANCIAL OFFICER

  • Officer
0 2021-07-27 2

HANDLEY MICHAEL K PRESIDENT AND CEO

  • Officer
  • Director
296,609 2021-07-27 2

SELSKY CLIFFORD CHIEF MEDICAL OFFICER

  • Officer
0 2021-07-27 2

MCAVOY COZETTE M. CHIEF LEGAL OFFICER

  • Officer
0 2021-07-27 2

BUCKHEIT ROBERT CHIEF TECHNOLOGY OFFICER

  • Officer
0 2021-07-27 2

MILLER LANGDON L CHIEF MEDICAL OFFICER

  • Officer
0 2021-07-22 1

ZOSH CHRISTOPHER VICE PRESIDENT OF FINANCE

  • Officer
0 2019-12-13 0

FEDYUNIN IVAN

  • Director
0 2018-08-10 0

SZYDLO JOHN EDWARD PRINCIPAL FINANCIAL OFFICER

  • Officer
273 2017-04-21 0

ANDRYUSHECHKIN ALEXANDER

  • Director
0 2016-07-21 0

TALYANSKIY DANIIL

  • Director
0 2016-07-21 0

NECHAEV ALEXEY

  • Director
0 2016-04-14 0

PERSIYANOV IVAN

  • Director
0 2015-07-09 0

EVDOKIMOVA ANNA

  • Director
0 2015-07-09 0

LEBEDINA YULIA

  • Director
0 2015-07-09 0

GORSHKOV KONSTANTIN

  • Director
0 2015-07-09 0

SARAEVA NATALIA

  • Director
0 2015-07-09 0

KHUDYK NATALIA

  • Director
0 2015-07-09 0

LEVINA TATIANA

  • Director
0 2015-07-09 0

ANTAL JAMES

  • Director
0 2015-04-22 0

LYONS C NEIL CHIEF FINANCIAL OFFICER

  • Officer
0 2015-04-22 0

PRINCIPI ANTHONY

  • Director
0 2015-04-22 0

GUDKOV ANDREI V CHIEF SCIENTIFIC OFFICER

  • Officer
  • Director
0 2015-04-22 0

KOGAN YAKOV CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2015-04-22 0

MCGOWAN RICHARD

  • Director
0 2015-04-22 0

KASIMOVA ELENA

  • Director
0 2015-04-22 0

BROWN JULIA R

  • Director
116,482 2015-01-08 0

MOGUTOV MIKHAIL

  • 10% Owner
5,286,344 2014-06-20 0

HOTH DANIEL FLOYD JR

  • Director
0 2014-06-11 0

POLINSKY ALEXANDER

  • Director
0 2014-06-11 0

HOHN DAVID C

  • Director
43,049 2014-03-13 0

DICORLETO PAUL E

  • Director
41,968 2013-06-19 0

FONSTEIN MICHAEL PRESIDENT

  • Officer
  • Director
0 2013-05-13 0

VIALLET JEAN CHIEF DEVELOPMENT OFFICER

  • Officer
0 2013-04-03 0

KASTEN BERNARD L

  • Director
0 2012-10-25 0

MARHOFER JOHN A JR CHIEF FINANCIAL OFFICER

  • Officer
0 2011-03-21 0

PEREZ HECTOR DANIEL

  • Director
12,749 2010-06-08 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MARKVICKA TAUNIA - Director - Officer CHIEF OPERATING OFFICER

2021-09-30 16:41:27 -0400 2021-09-28 A 100,000 a 100,000 direct 1.31 -2.6201 78.1659 78.1659 31 -3.9301 5

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
STATERA BIOPHARMA INC STAB 2021-11-26 22:15:03 UTC -16.7964 16.8664 550000
STATERA BIOPHARMA INC STAB 2021-11-26 21:45:03 UTC -16.7964 16.8664 550000
STATERA BIOPHARMA INC STAB 2021-11-26 21:15:03 UTC -16.7964 16.8664 550000
STATERA BIOPHARMA INC STAB 2021-11-26 20:45:03 UTC -16.7964 16.8664 550000
STATERA BIOPHARMA INC STAB 2021-11-26 20:15:03 UTC -16.7964 16.8664 550000
STATERA BIOPHARMA INC STAB 2021-11-26 19:45:04 UTC -16.7964 16.8664 550000
STATERA BIOPHARMA INC STAB 2021-11-26 19:15:03 UTC -16.7964 16.8664 550000
STATERA BIOPHARMA INC STAB 2021-11-26 18:45:04 UTC -18.1197 18.1897 550000
STATERA BIOPHARMA INC STAB 2021-11-26 18:15:04 UTC -18.1197 18.1897 550000
STATERA BIOPHARMA INC STAB 2021-11-26 17:45:03 UTC -18.1197 18.1897 550000
STATERA BIOPHARMA INC STAB 2021-11-26 17:15:03 UTC -18.1197 18.1897 550000
STATERA BIOPHARMA INC STAB 2021-11-26 16:45:03 UTC -18.4236 18.4936 550000
STATERA BIOPHARMA INC STAB 2021-11-26 16:15:03 UTC -18.4236 18.4936 550000
STATERA BIOPHARMA INC STAB 2021-11-26 15:45:03 UTC -18.4236 18.4936 550000
STATERA BIOPHARMA INC STAB 2021-11-26 15:15:02 UTC -18.4236 18.4936 550000
STATERA BIOPHARMA INC STAB 2021-11-26 14:45:03 UTC -17.581 17.651 550000
STATERA BIOPHARMA INC STAB 2021-11-26 14:15:03 UTC -17.581 17.651 550000
STATERA BIOPHARMA INC STAB 2021-11-26 13:45:04 UTC -17.581 17.651 550000
STATERA BIOPHARMA INC STAB 2021-11-26 13:15:03 UTC -17.581 17.651 550000
STATERA BIOPHARMA INC STAB 2021-11-26 12:45:04 UTC -17.581 17.651 550000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments